137 related articles for article (PubMed ID: 27511884)
61. Transcriptome Reprogramming of CD11b
Maia J; Otake AH; Poças J; Carvalho AS; Beck HC; Magalhães A; Matthiesen R; Strano Moraes MC; Costa-Silva B
Front Cell Dev Biol; 2020; 8():592518. PubMed ID: 33330473
[TBL] [Abstract][Full Text] [Related]
62. Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer?
Huart C; Chen JW; Le Calvé B; Michiels C; Wéra AC
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635552
[TBL] [Abstract][Full Text] [Related]
63. Toll-like Receptors from the Perspective of Cancer Treatment.
Javaid N; Choi S
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32012718
[TBL] [Abstract][Full Text] [Related]
64. Sepsis inhibits tumor growth in mice with cancer through Toll-like receptor 4-associated enhanced Natural Killer cell activity.
Vigneron C; Mirouse A; Merdji H; Rousseau C; Cousin C; Alby-Laurent F; Mira JP; Chiche JD; Llitjos JF; Pène F
Oncoimmunology; 2019; 8(11):e1641391. PubMed ID: 31646090
[TBL] [Abstract][Full Text] [Related]
65. Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy.
Peng H; Chen R; Brentnall TA; Eng JK; Picozzi VJ; Pan S
Clin Proteomics; 2019; 16():31. PubMed ID: 31346328
[TBL] [Abstract][Full Text] [Related]
66. TAMing pancreatic cancer: combat with a double edged sword.
Lankadasari MB; Mukhopadhyay P; Mohammed S; Harikumar KB
Mol Cancer; 2019 Mar; 18(1):48. PubMed ID: 30925924
[TBL] [Abstract][Full Text] [Related]
67. Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.
Malhotra A; Sharma U; Puhan S; Chandra Bandari N; Kharb A; Arifa PP; Thakur L; Prakash H; Vasquez KM; Jain A
Biochimie; 2019 Jan; 156():148-157. PubMed ID: 30326253
[TBL] [Abstract][Full Text] [Related]
68. Low dose radiation primed iNOS + M1macrophages modulate angiogenic programming of tumor derived endothelium.
Nadella V; Singh S; Jain A; Jain M; Vasquez KM; Sharma A; Tanwar P; Rath GK; Prakash H
Mol Carcinog; 2018 Nov; 57(11):1664-1671. PubMed ID: 30035346
[TBL] [Abstract][Full Text] [Related]
69. Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment.
Martin A; Seignez C; Racoeur C; Isambert N; Mabrouk N; Scagliarini A; Reveneau S; Arnould L; Bettaieb A; Jeannin JF; Paul C
Oncotarget; 2018 Jun; 9(47):28364-28378. PubMed ID: 29983866
[TBL] [Abstract][Full Text] [Related]
70. Inhibitors of Apoptosis Protein Antagonists (Smac Mimetic Compounds) Control Polarization of Macrophages during Microbial Challenge and Sterile Inflammatory Responses.
Nadella V; Mohanty A; Sharma L; Yellaboina S; Mollenkopf HJ; Mazumdar VB; Palaparthi R; Mylavarapu MB; Maurya R; Kurukuti S; Rudel T; Prakash H
Front Immunol; 2017; 8():1792. PubMed ID: 29375545
[TBL] [Abstract][Full Text] [Related]
71. Lipopolysaccharide (LPS)-mediated priming of toll-like receptor 4 enhances oxidant-induced prostaglandin E
Zhang Y; Igwe OJ
Int Immunopharmacol; 2018 Jan; 54():226-237. PubMed ID: 29161659
[TBL] [Abstract][Full Text] [Related]
72. High-Throughput Sequencing and Co-Expression Network Analysis of lncRNAs and mRNAs in Early Brain Injury Following Experimental Subarachnoid Haemorrhage.
Peng J; Wu Y; Tian X; Pang J; Kuai L; Cao F; Qin X; Zhong J; Li X; Li Y; Sun X; Chen L; Jiang Y
Sci Rep; 2017 Apr; 7():46577. PubMed ID: 28417961
[TBL] [Abstract][Full Text] [Related]
73. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer.
Grimmig T; Moench R; Kreckel J; Haack S; Rueckert F; Rehder R; Tripathi S; Ribas C; Chandraker A; Germer CT; Gasser M; Waaga-Gasser AM
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941651
[TBL] [Abstract][Full Text] [Related]
74. CD14 is a key organizer of microglial responses to CNS infection and injury.
Janova H; Böttcher C; Holtman IR; Regen T; van Rossum D; Götz A; Ernst AS; Fritsche C; Gertig U; Saiepour N; Gronke K; Wrzos C; Ribes S; Rolfes S; Weinstein J; Ehrenreich H; Pukrop T; Kopatz J; Stadelmann C; Salinas-Riester G; Weber MS; Prinz M; Brück W; Eggen BJ; Boddeke HW; Priller J; Hanisch UK
Glia; 2016 Apr; 64(4):635-49. PubMed ID: 26683584
[TBL] [Abstract][Full Text] [Related]
75. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
76. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer.
Farajzadeh Valilou S; Keshavarz-Fathi M; Silvestris N; Argentiero A; Rezaei N
Cytokine Growth Factor Rev; 2018 Feb; 39():46-61. PubMed ID: 29373197
[TBL] [Abstract][Full Text] [Related]
77. CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma.
Prakash H; Nadella V; Singh S; Schmitz-Winnenthal H
Sci Rep; 2016 Aug; 6():31490. PubMed ID: 27511884
[TBL] [Abstract][Full Text] [Related]
78. Palmitic acid combined with γ-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages' polarization via the TLR4 pathway.
Zhang YY; Li J; Li F; Xue S; Xu QY; Zhang YQ; Feng L
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7053-7067. PubMed ID: 36862159
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
